Literature DB >> 16113150

Feeding growth restricted preterm infants with abnormal antenatal Doppler results.

J Dorling1, S Kempley, A Leaf.   

Abstract

Absence or reversal of end diastolic flow (AREDF) in the umbilical artery is associated with poor outcome, and elective premature delivery is common. Feeding these infants is a challenge. They often have poor tolerance of enteral feeding, and necrotising enterocolitis may develop. This review explores current practice to see if there is evidence on which to base guidelines. The incidence of necrotising enterocolitis is increased in infants with fetal AREDF, especially when complicated by fetal growth restriction. Abnormalities of splanchnic blood flow persist postnatally, with some recovery during the first week of life, providing justification for a delayed and careful introduction of enteral feeding. Such a policy exposes babies to the risks of parenteral nutrition, with no trials to date showing any benefit of delayed enteral nutrition. Trials are required to determine the optimum timing for introduction of enteral feeds in growth restricted infants with fetal AREDF.

Entities:  

Mesh:

Year:  2005        PMID: 16113150      PMCID: PMC1721930          DOI: 10.1136/adc.2004.060350

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  49 in total

1.  Morbidity and mortality among very-low-birth-weight neonates with intrauterine growth restriction. The Vermont Oxford Network.

Authors:  I M Bernstein; J D Horbar; G J Badger; A Ohlsson; A Golan
Journal:  Am J Obstet Gynecol       Date:  2000-01       Impact factor: 8.661

Review 2.  Minimizing risks associated with peripherally inserted central catheters in the NICU.

Authors:  D Camara
Journal:  MCN Am J Matern Child Nurs       Date:  2001 Jan-Feb       Impact factor: 1.412

3.  Randomized comparative trial between percutaneous longlines and peripheral cannulae in the delivery of neonatal parenteral nutrition.

Authors:  S B Ainsworth; J Furness; A C Fenton
Journal:  Acta Paediatr       Date:  2001-09       Impact factor: 2.299

4.  Fetal superior mesenteric artery blood flow velocimetry in normal and high-risk pregnancy.

Authors:  Przemyslaw Korszun; Mariusz Dubiel; Grzegorz Breborowicz; Anna Danska; Saemundur Gudmundsson
Journal:  J Perinat Med       Date:  2002       Impact factor: 1.901

5.  Prenatal hemodynamic disturbances -- pathophysiological background of intestinal motility disturbances in small for gestational age infants.

Authors:  E Robel-Tillig; C Vogtmann; J Bennek
Journal:  Eur J Pediatr Surg       Date:  2002-06       Impact factor: 2.191

6.  Arterial and venous Doppler velocimetry in the severely growth-restricted fetus and associations with adverse perinatal outcome.

Authors:  T Ozcan; M Sbracia; R L d'Ancona; J A Copel; G Mari
Journal:  Ultrasound Obstet Gynecol       Date:  1998-07       Impact factor: 7.299

7.  Superior mesenteric artery blood flow velocity in small for gestational age infants of very low birth weight during the early neonatal period.

Authors:  K Maruyama; T Koizumi
Journal:  J Perinat Med       Date:  2001       Impact factor: 1.901

8.  Necrotizing enterocolitis in infants born to women with severe early preeclampsia and absent end-diastolic umbilical artery doppler flow velocity waveforms.

Authors:  G F Kirsten; N van Zyl; M Smith; H Odendaal
Journal:  Am J Perinatol       Date:  1999       Impact factor: 1.862

Review 9.  Minimal enteral nutrition for promoting feeding tolerance and preventing morbidity in parenterally fed infants.

Authors:  J E Tyson; K A Kennedy
Journal:  Cochrane Database Syst Rev       Date:  2000

Review 10.  Early versus delayed initiation of progressive enteral feedings for parenterally fed low birth weight or preterm infants.

Authors:  K A Kennedy; J E Tyson; S Chamnanvanikij
Journal:  Cochrane Database Syst Rev       Date:  2000
View more
  24 in total

Review 1.  Nutritional support in the premature newborn.

Authors:  J W L Puntis
Journal:  Postgrad Med J       Date:  2006-03       Impact factor: 2.401

2.  Management of infants with intra-uterine growth restriction.

Authors:  Ashok K Deorari; Ramesh Agarwal; Vinod K Paul
Journal:  Indian J Pediatr       Date:  2008-02       Impact factor: 1.967

3.  The feeding conundrum.

Authors:  Sreeram Subramanian; Srinivas Murki
Journal:  Transl Pediatr       Date:  2017-04

Review 4.  A critical analysis of risk factors for necrotizing enterocolitis.

Authors:  Allison Thomas Rose; Ravi Mangal Patel
Journal:  Semin Fetal Neonatal Med       Date:  2018-08-01       Impact factor: 3.926

5.  Hypoxic-ischemic enterocolitis: a proposal of a new terminology for early NEC or NEC-like disease in preterm infants, a single-center prospective observational study.

Authors:  Ozge Surmeli Onay; Ayse Korkmaz; Sule Yigit; Murat Yurdakok
Journal:  Eur J Pediatr       Date:  2019-12-18       Impact factor: 3.183

6.  Splanchnic-cerebral oxygenation ratio (SCOR) values in healthy term infants as measured by near-infrared spectroscopy (NIRS).

Authors:  Sean M Bailey; Karen D Hendricks-Muñoz; Pradeep Mally
Journal:  Pediatr Surg Int       Date:  2013-02-28       Impact factor: 1.827

Review 7.  Pathophysiology and current management of necrotizing enterocolitis.

Authors:  Himabindu Kasivajjula; Akhil Maheshwari
Journal:  Indian J Pediatr       Date:  2014-03-22       Impact factor: 1.967

Review 8.  Slow advancement of enteral feed volumes to prevent necrotising enterocolitis in very low birth weight infants.

Authors:  Sam J Oddie; Lauren Young; William McGuire
Journal:  Cochrane Database Syst Rev       Date:  2017-08-30

9.  Feeding of low birth weight infants.

Authors:  M Jeeva Sankar; Ramesh Agarwal; Satish Mishra; Ashok K Deorari; Vinod K Paul
Journal:  Indian J Pediatr       Date:  2008-06-08       Impact factor: 1.967

10.  ADEPT - Abnormal Doppler Enteral Prescription Trial.

Authors:  Alison Leaf; Jon Dorling; Steve Kempley; Kenny McCormick; Paul Mannix; Peter Brocklehurst
Journal:  BMC Pediatr       Date:  2009-10-02       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.